Sedation and performance issues in the treatment of allergic conditions.

This article evaluates and summarizes the results of studies investigating the central nervous system effects of second-generation antihistamines, with particular emphasis on psychomotor and cognitive effects. The data sources were computer-assisted MEDLINE searches using the search terms histamine H1 antagonists, psychomotor performance, sleep, and specific drug names, including astemizole, cetirizine, loratadine, and terfenadine; the searches were limited to studies in humans. Only controlled studies (placebo or active control or both) using standardized or quantitative methods for defining drug-induced effects on sedation, psychomotor performance, or cognition were reviewed. Additional published studies were identified within the references of the first group of studies. Finally, representative studies were selected for summarization. Objective and subjective measures of sedation show that loratadine and terfenadine produce sedation at a rate comparable with placebo. Moreover, these agents, when used at standard therapeutic doses, do not produce detrimental effects on objective measures of psychomotor or cognitive function. Cetirizine is associated with sedation or psychomotor impairment in some studies but not in others. The data on central nervous system effects of astemizole are limited and were not evaluated. The absence of sedation and psychomotor or cognitive impairment in patients receiving loratadine or terfenadine justifies the cost of these agents, particularly for patients who drive, pilot aircraft, or operate machinery. Whether the potential for rare but serious cardiovascular events (associated with astemizole and terfenadine) is justifiable must be decided on a case-by-case basis.

[1]  R. Dockhorn,et al.  Double-blind comparison of cetirizine and placebo in the treatment of seasonal rhinitis. , 1991, Annals of allergy.

[2]  F. Gengo,et al.  The relative antihistaminic and psychomotor effects of hydroxyzine and cetirizine , 1987, Clinical pharmacology and therapeutics.

[3]  R. Neves-Pinto,et al.  A Double-Blind Study of the Effects of Loratadine versus Placebo on the Performance of Pilots , 1992 .

[4]  A. Barnett,et al.  Selective displacement of [3H]mepyramine from peripheral vs. central nervous system receptors by loratadine, a non-sedating antihistamine. , 1986, European journal of pharmacology.

[5]  J. Weiler,et al.  Safety and efficacy of loratadine (Sch-29851): a new non-sedating antihistamine in seasonal allergic rhinitis. , 1987, Annals of allergy.

[6]  D. Aaronson.  Effects of Terfenadine on Psychomotor Performance , 1993, Drug Safety.

[7]  S. Greenstein,et al.  Once daily loratadine versus astemizole once daily. , 1994, Annals of allergy.

[8]  Eliscer Guzman,et al.  Torsades de pointes induced by erythromycin and terfenadine. , 1994, The American journal of emergency medicine.

[9]  J. Rihoux,et al.  Comparative study of the peripheral and central effects of terfenadine and cetirizine 2 HCl. , 1987, Annals of allergy.

[10]  J. Hébert,et al.  Comparison of the efficacy and safety of loratadine, terfenadine, and placebo in the treatment of seasonal allergic rhinitis. , 1988, The Journal of allergy and clinical immunology.

[11]  T. Roth,et al.  Sedative effects of antihistamines. , 1987, The Journal of allergy and clinical immunology.

[12]  J. K. Walsh,et al.  Simulated assembly line performance following ingestion of cetirizine or hydroxyzine. , 1992, Annals of allergy.

[13]  B. Adelsberg,et al.  560 The effects of loratadine, diphenhydramine and placebo on worker productivity: Results of a double blind trial , 1991 .

[14]  R. Miller,et al.  The effects of phenindamine tartrate on sleepiness and psychomotor performance. , 1992, The Journal of allergy and clinical immunology.

[15]  H. L. Snyder,et al.  The effects of Benadryl and Hismanal on psychomotor performance and perceived performance. , 1993, Aviation, space, and environmental medicine.

[16]  D. Faulds,et al.  Cetirizine : A Reappraisal of its Pharmacological Properties and Therapeutic Use in Selected Allergic Disorders. , 1993, Drugs.

[17]  F. Gengo,et al.  Quantitative effects of cetirizine and diphenhydramine on mental performance measured using an automobile driving simulator. , 1990, Annals of allergy.

[18]  P. Cauwenberge.  New Data on the Safety of Loratadine , 1992 .

[19]  F. Simons,et al.  H1-Receptor Antagonists , 1994, Drug safety.

[20]  O'Hanlon Jf.  Antihistamines and driving safety. , 1988 .

[21]  H. Roberts,et al.  How many people think they have hay fever, and what they do about it. , 1992, The British journal of general practice : the journal of the Royal College of General Practitioners.

[22]  J. O'hanlon,et al.  Seasonal allergic rhinitis and antihistamine effects on children's learning , 1992, European Neuropsychopharmacology.

[23]  P. McMenamin.  Costs of hay fever in the United States in 1990. , 1994, Annals of allergy.

[24]  C. Ellis,et al.  Pharmacologic therapy for urticaria. , 1991, Journal of the American Academy of Dermatology.

[25]  J. Hébert,et al.  Efficacy and safety of loratadine (10 mg once daily), terfenadine (60 mg twice daily), and placebo in the treatment of seasonal allergic rhinitis. , 1989, The Journal of allergy and clinical immunology.

[26]  Roman Ij,et al.  Loratadine. A review of recent findings in pharmacology, pharmacokinetics, efficacy, and safety, with a look at its use in combination with pseudoephedrine. , 1993 .

[27]  F. Gengo,et al.  Antihistamines, drowsiness, and psychomotor impairment: central nervous system effect of cetirizine. , 1987, Annals of allergy.